| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |